Abstract:A series of 10-amino-6,8,12,12a-tetrahydro-5H-thiazolo[4',5':4,5]pyrido[2,1-a] isoquinolines with substituent hydroxyl or methoxyl groups at C2 and C3 positions of the benzene ring were designed and synthesized. These compounds are 2-aminothiazole bioisosteres of the natural product stepholidine (SPD). Radioligand binding assays showed that compounds 10a, 10b, 10c and 12b had moderate binding affinity and activity for the D1 receptor, as well as high selectivity over the D2 receptor. Among them, 10c exhibited moderate D3 receptor binding affinity. 10a with an amino group in position 10 showed higher affinities toward D3 receptor compared to those without an amino group. In silico docking analysis of active ligands was performed to explain the result of binding assays and analyze structure-activity relationship for further structure optimization. Our analysis suggested that besides the salt bridge interaction formed by the conserved D3.32 with the protonated nitrogen of ligands and the hydrogen bonds formed by S5.42 with 2-hydroxyl group and S5.46 with 3-methoxyl group, a hydrogen bond formed between S188 located on the second extracellular loop (ECL2) and the nitrogen in the thiazole ring was critical to the affinity of this series of compounds for the D1 receptor, which was in agreement with the interaction mode between SPD and the D1 receptor. Â Our results suggested that the introduction of thiazole ring changes the pharmacological profile of SPD and the optimized compounds have high selective activity to D1 receptor over D2 receptor. These thiazole-SPD-derivative compounds have potential clinical use in Parkinsonâ€™s disease and other conditions related to dopamine receptors.

Discovery of Thiadiazole Amides As Potent, S1p(3)-Sparing Agonists of Sphingosine-1-Phosphate 1 (s1p(1)) Receptor

Discovery of Novel 1,2,4-Thiadiazole Derivatives As Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P(1)).

Identification of benzoxazole analogs as novel, S1P3 sparing S1P1 agonists

Indole-propionic acid derivatives as potent, S1P 3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P 1) receptor agonists

Discovery of 3‐(2‐aminoethyl)‐thiazolidine‐2,4‐diones as a Novel Chemotype of Sigma‐1 Receptor Ligands

Structure−Activity Relationship Studies and in Vivo Activity of Guanidine-Based Sphingosine Kinase Inhibitors: Discovery of SphK1- and SphK2-Selective Inhibitors

Discovery, Synthesis and Biological Evaluation of 2-(4-(n-phenethylsulfamoyl)phenoxy)acetamides (sapas) As Novel Sphingomyelin Synthase 1 Inhibitors

Discovery of (S)-3-(4-(benzyloxy)phenyl)-2-(2-phenoxyacetamido)propanoic Acid Derivatives As a New Class of GPR34 Antagonists.

Discovery of a 4-Aryloxy-1h-pyrrolo[3,2-c]pyridine and a 1-Aryloxyisoquinoline Series of TRPA1 Antagonists

Design,Synthesis and Biological Evaluation of Potent and Selective S1PR1 Agonists for the Treatment of Ulcerative Colitis

Discovery And Optimization Of Potent Gpr40 Full Agonists Containing Tricyclic Spirocycles

Synthesis, Preliminary Pharmacological Evaluation and Receptor Docking Studies of 10-Amino-3-methoxy-6,8,12,12a-tetrahydro-5h-thiazolo[4',5':4,5]Pyrido[2,1-a]isoquinolin-2-ols As Novel Dopamine D1 Receptor Inhibitors

Design, Synthesis, and in Vitro Bioactivity Evaluation of Fluorine-Containing Analogues for Sphingosine-1-phosphate 2 Receptor.

Α-Aryl Pyrrolidine Sulfonamides As TRPA1 Antagonists

Discovery of N-cyclobutylaminoethoxyisoxazole Derivatives As Novel Sigma-1 Receptor Ligands with Neurite Outgrowth Efficacy in Cells

Discovery of Biaryl Amides As Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.

Discovery of 4-Benzyloxybenzo[d]isoxazole-3-amine Derivatives As Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors That Reduce Chronic Inflammation in Db/db Mice

3D-QSAR Studies on Thiazolidin-4-one S1P1 Receptor Agonists by CoMFA and CoMSIA

Discovery of adamantane ethers as inhibitors of 11β-HSD-1: Synthesis and biological evaluation

Discovery of the Selective Sphingomyelin Synthase 2 Inhibitors with the Novel Structure of Oxazolopyridine

Structural insights into sphingosine 1-phosphate receptor 4 activation